Rapid Test 2019-nCoV Total Antibody

The Rapid Test 2019-nCoV Total Ig S is a lateral flow test for the detection of total Immunoglobulins (IgA, IgG and IgM) against SARS-CoV-2 in whole blood, human serum or plasma specimens.

This test is allowed to be marketed under policy D of the FDA Policy for Diagnostic Tests for Coronavirus Disease 2019 during the Public Health Emergency; Immediately in Effect Guidance for Clinical Laboratories, Commercial Manufacturers, and Food and Drug Administration Staff document issued March 16, 2020.



CLICK HERE TO DOWNLOAD OUR Rapid Test 2019-nCoV Total Antibody BROCHURE CLICK HERE TO DOWNLOAD OUR Rapid Test 2019-nCoV Total Antibody BROCHURE